1 completed, 1 recruiting, 1 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Recruiting 1, Unknown 1 |
Follow Dual Antiplatelet Therapy: new trials by email Literature Review of Dual Antiplatelet Therapy trials Research Report on Dual Antiplatelet Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting De-escalated Dual Antiplatelet Therapy, Dual Antiplatelet Therapy - Coronary Artery Disease, Coronary Artery Bypass Grafting | Phase 4 | Completed | China National Center for Cardiovascular Diseases | 2300 | 2023-02-14 | 2025-08-27 |
| Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients Prasugrel based short DAPT, Prasugrel based standard DAPT, OCT guided revascularization - ST Elevated Myocardial Infarction, Dual Antiplatelet Therapy | Phase 4 | Recruiting | Research Maatschap Cardiologen Rotterdam Zuid | 1656 | 2022-07-22 | 2026-07-02 |
| Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease 1 month DAPT, 6 months DAPT - Coronary Disease, Drug Eluting Stent | Phase 4 | Unknown | Shanghai MicroPort Medical (Group) Co., Ltd. | 1720 | 2019-06-01 | 2020-09-09 |
Angina Pectoris (1) · Coronary Artery Disease (1) · Coronary Disease (1) · Hemorrhage (1) · Myocardial Infarction (1) · Myocardial Ischemia (1) · ST Elevation Myocardial Infarction (1)
Cardiovascular Diseases (3) · Heart Diseases (3) · Vascular Diseases (3) · Infarction (2) · Ischemia (2) · Myocardial Ischemia (2) · Necrosis (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Chest Pain (1) · Coronary Disease (1) · Myocardial Infarction (1) · Neurologic Manifestations (1)
2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine (1)
China National Center for Cardiovascular Diseases (1) · Research Maatschap Cardiologen Rotterdam Zuid (1) · Shanghai MicroPort Medical (Group) Co., Ltd. (1)
China (2) · Belgium (1) · Czechia (1) · Germany (1) · Italy (1) · Netherlands (1) · Serbia (1)
Kai Chen (1) · Qing Chu, PhD (1) · Shengshou Hu, MD (1) · Valeria Paradies, MD, PhD (1) · Xin Yuan, PhD (1) · Yaling Han, MD (1)
PMID 34503738, PMID 34503739, PMID 37385747, PMID 40375771, PMID 42120081